Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI plus ZD4054 versus FOLFIRI plus placebo in oxaliplatin-pretreated advanced colorectal cancer
ISRCTN73199181Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Sep 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of zibotentan in colorectal cancer (CRC), sponsored by Cardiff University. Primary endpoint: Progression-free survival at 16 weeks. Started Sep 2009; status: completed.
02
Drugs
zibotentan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN73199181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73199181.